Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1595 (LINC01595) is a member of the long intergenic non-coding RNA (lincRNA) subclass, which are defined as autonomously transcribed RNA molecules longer than 200 nucleotides that do not overlap with protein-coding genes[1]. LincRNAs, including LINC01595, are typically not translated into proteins and function in the regulation of chromatin structure, transcriptional regulation of gene expression, and maintenance of genome architecture[1]. Many lincRNAs exhibit tissue-specific expression and may modulate the expression of neighboring genes via enhancer-like or other regulatory mechanisms[1]. While some lincRNAs contribute to cellular processes and have known roles in disease, direct evidence for functional or disease associations with LINC01595 specifically is currently lacking in the literature. No small-molecule or biologic drugs are known to specifically target LINC01595, and it is not regarded as a canonical therapeutic target such as a receptor, enzyme, transporter, or transcription factor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1595 (LINC01595).